About Leucovorin Rescue

The Leucovorin Rescue Dose Calculator is designed to assist healthcare professionals in creating a dosing schedule for leucovorin (folinic acid) following the administration of high-dose methotrexate (HD-MTX). Leucovorin rescue is a critical intervention that selectively protects healthy cells from the toxic effects of methotrexate by replenishing the body’s folate stores, without compromising the drug’s anticancer activity.

Calculator Outputs Explained

Upon entering the required patient and treatment data, the calculator generates a detailed, time-based rescue schedule. Key outputs include:

• Timed Dosing Schedule: A list of leucovorin doses with the exact date and time for administration, referenced from the start of the MTX infusion (e.g., +24h, +30h, +36h).
• Calculated Doses: Each dose is provided in mg/m² and as a total dose in mg based on the patient’s Body Surface Area (BSA).
• Dose Escalation Alerts: If provided serum methotrexate levels exceed protocol-defined thresholds at specific time points (e.g., 48 or 72 hours), the tool will automatically adjust the leucovorin dose and frequency and display a high-priority alert.

How to Use the Calculator

To generate an accurate leucovorin rescue schedule, follow these steps:

1. Enter Patient Metrics: Input the patient’s weight and height. The tool calculates BSA using the Mosteller formula. A manual override option is available if a specific BSA value is required.
2. Set Infusion Time: Provide the precise start date and time of the high-dose methotrexate infusion. This is the “zero hour” from which all rescue doses are timed.
3. Select Protocol: Choose the appropriate rescue protocol, typically a standard rescue beginning at 24 hours or a delayed rescue protocol starting at 42 hours post-MTX infusion.
4. Input MTX Levels (Optional): For dose adjustment, enter serum methotrexate levels as they become available. The calculator uses these values to check against nomogram thresholds and determine if dose escalation is needed to prevent toxicity.

Dosing Overview

Leucovorin rescue dosing is guided by institutional protocols and nomograms that correlate serum MTX levels with the risk of toxicity. A common starting dose is 15 mg/m² administered intravenously or orally every 6 hours. This schedule continues until serum methotrexate levels fall below a safe threshold (e.g., < 0.1 µmol/L).

If MTX clearance is delayed (indicated by levels above the nomogram line), the leucovorin dose is significantly increased (e.g., to 100-150 mg/m²) and the frequency is shortened (e.g., every 3 hours) to ensure adequate rescue and prevent severe side effects like myelosuppression, mucositis, and nephrotoxicity.

Switching from IV to Oral Administration

Patients may be switched from intravenous (IV) to oral (PO) leucovorin once they can tolerate oral medications, are well-hydrated, and have demonstrated adequate and declining methotrexate levels. The decision to switch should be based on clinical assessment and institutional guidelines. The bioavailability of oral leucovorin is excellent at standard doses, but IV administration is preferred for high-dose rescue or in patients with gastrointestinal issues.

Handling a Missed Dose

If a dose of leucovorin is missed, it is critical to contact the prescribing oncologist or clinical pharmacist immediately for guidance. Do not administer a double dose to compensate for the missed one. The medical team will provide instructions based on the patient’s current MTX level, renal function, and the time elapsed since the last dose.

Safety Alerts & Monitoring

Effective leucovorin rescue depends on a comprehensive monitoring strategy:

• Hydration and Alkalinization: Patients receiving HD-MTX must maintain vigorous hydration and urinary alkalinization (urine pH > 7.0) to promote MTX excretion and prevent crystallization in the kidneys.
• Renal Function: Serum creatinine and urine output should be monitored closely, as MTX-induced nephrotoxicity can severely delay drug clearance, creating a cycle of increasing toxicity.
• MTX Levels: Regular monitoring of serum methotrexate concentration is mandatory to guide the duration and intensity of the leucovorin rescue.

Frequently Asked Questions (FAQ)

What BSA formula does the calculator use?

The calculator uses the Mosteller formula: BSA (m²) = √([Height(cm) × Weight(kg)] / 3600). You can also manually override this by checking the corresponding box and entering a known BSA value.

What happens if a patient’s 48-hour MTX level is too high?

If you input a 48-hour MTX level that exceeds the protocol’s threshold, the calculator will issue a “Dose Escalation Required” alert and recalculate the subsequent dosing schedule with a higher dose (e.g., 100 mg/m²) and increased frequency (e.g., every 3 hours) as per typical high-risk nomograms.

What is the difference between the “Standard (24h)” and “Delayed (42h)” protocols?

The primary difference is the start time of the first leucovorin dose relative to the beginning of the MTX infusion. The choice of protocol depends on the specific HD-MTX regimen and institutional practice.

Can I enter MTX levels in different units?

Yes, the tool allows you to select either micromoles per liter (µmol/L) or nanomoles per liter (nmol/L) for each MTX level entry. The calculator automatically converts all values to µmol/L for internal calculations.

Does this tool account for renal impairment?

No. The calculator assumes normal renal function. Patients with pre-existing or developing renal impairment require specialized management by an experienced oncology team, as MTX clearance will be significantly delayed.

How long should leucovorin rescue continue?

Leucovorin is typically continued until the serum methotrexate level falls below a safe, non-toxic threshold, which is generally considered to be less than 0.1 µmol/L (or 1 x 10⁻⁷ M).

Is this calculator a substitute for professional medical advice?

Absolutely not. This is a clinical support tool for informational purposes. All treatment decisions must be made by a qualified healthcare professional based on a full clinical evaluation of the patient.

Why is dose rounding not applied?

The calculator provides precise, unrounded dose values to ensure accuracy. Doses should be rounded according to your institution’s specific pharmacy and nursing policies (e.g., to the nearest whole mg or available vial size).

References

• Leucovorin Calcium for Injection – FDA Prescribing Information
• Methotrexate for Injection – FDA Prescribing Information
• Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and Managing Toxicities of High-Dose Methotrexate. *Oncologist*. 2016;21(12):1471-1482. (via PubMed/NCBI)
• Methotrexate – National Cancer Institute (NCI)